MEDROXYPROGESTERONE ACETATE
- Product NDC
- 69097-539
- 11-digit product format
- 690970539
- Labeler code
- 69097
- Product ID
- 69097-539_3b389352-a6a3-45ea-9335-b3df361f7d87
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MEDROXYPROGESTERONE ACETATE
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Labeler
- Cipla USA Inc.
- Application
- ANDA210335
- Marketing category
- ANDA
- Marketing start
- 2019-01-25
- Marketing end
- 0000-00-00
- Substance
- MEDROXYPROGESTERONE ACETATE
- Active strength
- 150 mg/mL
- Pharmacologic classes
- Progesterone Congeners [CS],Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-539 | MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [CIPLA USA INC.] | 4 | Legacy NDC | 20210317_3d033fba-6313-4906-9d34-245423eaeeef.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-539-31 | 69097053931 | 1 VIAL, SINGLE-DOSE in 1 CARTON (69097-539-31) > 1 mL in 1 VIAL, SINGLE-DOSE | 2019-01-25 | 0000-00-00 | No | No | Current |